Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18


ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders.

Notzon DP, Pavlicova M, Glass A, Mariani JJ, Mahony AL, Brooks DJ, Levin FR.

J Atten Disord. 2016 Mar 31. pii: 1087054716640109. [Epub ahead of print]


Treatment of Cannabis Use Disorder: Current Science and Future Outlook.

Sherman BJ, McRae-Clark AL.

Pharmacotherapy. 2016 May;36(5):511-35. doi: 10.1002/phar.1747. Review.


Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.

Trigo JM, Lagzdins D, Rehm J, Selby P, Gamaleddin I, Fischer B, Barnes AJ, Huestis MA, Le Foll B.

Drug Alcohol Depend. 2016 Apr 1;161:298-306. doi: 10.1016/j.drugalcdep.2016.02.020. Epub 2016 Feb 23.


Attempts to stop or reduce daily cannabis use: An intensive natural history study.

Hughes JR, Naud S, Budney AJ, Fingar JR, Callas PW.

Psychol Addict Behav. 2016 May;30(3):389-97. doi: 10.1037/adb0000155. Epub 2016 Feb 1.


Maintenance Check-ups Following Treatment for Cannabis Dependence.

Walker DD, Stephens RS, Towe S, Banes K, Roffman R.

J Subst Abuse Treat. 2015 Sep;56:11-5. doi: 10.1016/j.jsat.2015.03.006. Epub 2015 Apr 11.


Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment.

Lee D, Schroeder JR, Karschner EL, Goodwin RS, Hirvonen J, Gorelick DA, Huestis MA.

Am J Addict. 2014 May-Jun;23(3):234-42. doi: 10.1111/j.1521-0391.2014.12088.x.


An exploratory study of cannabis withdrawal among Indigenous Australian prison inmates: study protocol.

Rogerson B, Copeland J, Buttner P, Bohanna I, Cadet-James Y, Sarnyai Z, Clough AR.

BMJ Open. 2013 May 28;3(5). pii: e002951. doi: 10.1136/bmjopen-2013-002951.


Characterization of individuals seeking treatment for caffeine dependence.

Juliano LM, Evatt DP, Richards BD, Griffiths RR.

Psychol Addict Behav. 2012 Dec;26(4):948-54. doi: 10.1037/a0027246. Epub 2012 Feb 27.


Pharmacological treatment of cannabis dependence.

Weinstein AM, Gorelick DA.

Curr Pharm Des. 2011;17(14):1351-8.


Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.

Levin FR, Mariani JJ, Brooks DJ, Pavlicova M, Cheng W, Nunes EV.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):142-50. doi: 10.1016/j.drugalcdep.2010.12.010. Epub 2011 Feb 18.


Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review.

Wilson N, Cadet JL.

J Addict Dis. 2009 Oct;28(4):309-19. doi: 10.1080/10550880903182960. Review.


Reactivity to cannabis cues in virtual reality environments.

Bordnick PS, Copp HL, Traylor A, Graap KM, Carter BL, Walton A, Ferrer M.

J Psychoactive Drugs. 2009 Jun;41(2):105-12.


Cocaine dependence and concurrent marijuana use: a comparison of clinical characteristics.

Lindsay JA, Stotts AL, Green CE, Herin DV, Schmitz JM.

Am J Drug Alcohol Abuse. 2009;35(3):193-8. doi: 10.1080/00952990902933860.


Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse.

Budney AJ, Vandrey RG, Hughes JR, Thostenson JD, Bursac Z.

J Subst Abuse Treat. 2008 Dec;35(4):362-8. doi: 10.1016/j.jsat.2008.01.002. Epub 2008 Mar 14.


Marijuana dependence and its treatment.

Budney AJ, Roffman R, Stephens RS, Walker D.

Addict Sci Clin Pract. 2007 Dec;4(1):4-16. Review.


Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse.

Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Foltin RW.

Psychopharmacology (Berl). 2008 Mar;197(1):157-68. Epub 2007 Dec 27.


Characteristics of cocaine- and marijuana-dependent subjects presenting for medication treatment trials.

McRae AL, Hedden SL, Malcolm RJ, Carter RE, Brady KT.

Addict Behav. 2007 Jul;32(7):1433-40. Epub 2006 Dec 5.

Supplemental Content

Support Center